FDA ANDA · ANDA206152
PIROXICAM
Sponsor: MICRO LABS
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA206152
TYPE
ANDA
ORIGINAL APPROVAL
2017-12-29
LATEST ACTION
2026-10-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
PIROXICAMPrescription
PIROXICAM 20MG · CAPSULE · ORAL
PIROXICAMPrescription
PIROXICAM 10MG · CAPSULE · ORAL
Approval history
2026-10-08Manufacturing (CMC) · Supplement 8 · unknownAP
2026-07-31Labeling · Supplement 7 · standardAP
2023-02-03Labeling · Supplement 5 · standardAP
2023-02-03Labeling · Supplement 6 · standardAP
2019-10-07Labeling · Supplement 1 · standardAP
2017-12-29UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →